Fundraising Fox
Cergentis
1 known investors
Find your way into Cergentis
Sign up to see every warm intro you have to Cergentis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cergentis team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cergentis is now part of Solvias and provides Targeted Locus Amplification (TLA) technology and genetic characterization services for advanced therapy development. The company serves pharmaceutical and biotech innovators with CMC analytical testing from drug development through commercialization.
Investors · 1
Frequently asked questions
- What does Cergentis do?
- Cergentis is now part of Solvias and provides Targeted Locus Amplification (TLA) technology and genetic characterization services for advanced therapy development. The company serves pharmaceutical and biotech innovators with CMC analytical testing from drug development through commercialization.
- Who are Cergentis's investors?
- Cergentis's investors include Novalis Biotech.